Clinical Trial Detail

NCT ID NCT00730158
Title A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

colorectal cancer

Therapies

Irinotecan

YIV-906

Age Groups: adult

No variant requirements are available.